Mattheos Falagas INFECTIONS DISEASE SPECIALIST Director, 1st Internal Medicine Department

• DSc, “The impact of cytomegalovirus (CMV) on short and long term survival of orthotopic liver transplant recipients”, Athens University School of Medicine, Athens, Greece

• Medical Association of Athens

Editorial Boards:

• Drug Resistance Updates
• European Journal of Clinical Microbiology and Infectious Diseases
• Expert Review of Anti-Infective Therapy
• Internationl Journal of Antimicrobial Agents
• Journal of Infection and Public Health
• Medscape Infectious Diseases
• PLoS ONE

Peer Reviewer for international journals:

• Annals of Internal Medicine
• Antimicrobial Agents and Chemotherapy
• British Medical Journal
• Clinical Infectious Diseases
• JAMA
• Journal of Antimicrobial Chemotherapy
• Lancet
• Lancet Infectious Diseases

• Director, Fourth Department of Internal Medicine, Henry Dunant Hospital Center, Athens, Greece
• Founder, President of the Executive Board, and Director, Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece (aibs.gr)

Education Experience:

• Mentor of about 100 research fellows and assistants

Clinical Interest:

• Management of difficult to diagnose and complex medical cases in the fields of Internal Medicine and Infectious Diseases

Research Interest: 

• Antimicrobial agents (including polymyxins and fosfomycin)
• Antimicrobial resistance
• Nosocomial infections
• Gram-negative bacterial infections (Acinetobacter, Pseudomonas, Klebsiella)
• Infections in immunosuppressed patients
• Estimates and determinants of research productivity
• Medical education

• Inclusion in the top-10 highly cited researchers in Greece
• Award for excellence in research, Greek Society of Emergency and Outpatient Medicine
• Maxwell Finland Young Investigator Award for Excellence in Research, Massachusetts Infectious Diseases Society
• Research Award (for the study: Cancer incidence after metronidazole use: a matched metronidazole user/non-user study), Amfiaraion Foundation for the Study of Chemotherapeutic Agents, 23rd Panhellenic Medical Conference, Athens, Greece
• Edward Kass Award for Clinical Excellence, Massachusetts Infectious Diseases Society
• House Staff Award for Excellence in Teaching, The Medical Student Body  State University of New York (SUNY) at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York

• Falagas ME, Mylonakis E (editors). Gorbach’s 5-Minute Infectious Diseases Consult (textbook), 2nd edition. Lippincott, Williams &Wilkins, Philadephia, Pensylvania, 2012.
• Gorbach SL, Falagas ME (editors). 5-Minute Infectious Diseases Consult (textbook), 1st edition. Lippincott, Williams &Wilkins, Philadephia, Pensylvania, 2001.
• Gorbach SL, Bartlett JG, Falagas ME, Hamer D. Guidelines for Infectious Diseases in Primary Care (handbook). Lippincott Williams and Wilkins, Philadelphia, Pensylvania, 1999.

• Tsegka KG, Voulgaris GL, Kyriakidou M, Falagas ME. Intravenous fosfomycin for the treatment of patients with bone and joint infections. Expert Rev Anti Infect Ther 2021; doi: 10.1080.
• Falagas ME, Kyriakidou M, Voulgaris GL, Vokos F, Politi S, Kechagias KS. Clinical use of intravenous polymyxin B for the treatment of patients with multidrug-resistant Gram-negative bacterial infections: An evaluation of the current evidence. J Glob Antimicrob Resist 2021; doi: 10.1016.
• Rafailidis PI, Falagas ME. Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectives. Expert Rev Anti Infect Ther 2020; doi: 10.1080.
• Falagas ME, Voulgaris GL, Tryfinopoulou K, Giakkoupi P, Kyriakidou M, Vatopoulos A, Coates A, Hu Y. Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals. Int J Antimicrob Agents 2019; doi: 10.1016.
• Vardakas KZ, Kyriakidou M, Apiranthiti KN, Almpani SE, Heliou D, Stratigopoulou D, Giourmetaki E, Lamprou D, Binou G, Mpaltzoglou E, Falagas ME. Trends of mortality in Greece prior to and during its current financial crisis (2009-2015). Rambam Maimonides Med J 2019; doi: 10.5041.
• Falagas ME, Skalidis T, Vardakas KZ, Voulgaris GL, Papanikolaou G, Legakis N, Hellenic TP-6076 Study Group. Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals. Int J Antimicrob Agents 2018;52:269-271.
• Vardakas KZ, Voulgaris GL, Maliaros A, Samonis G, Falagas ME. Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis 2018;18:108-120.
• Falagas ME, Karageorgopoulos DK. Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet 2010;375:248-51. 
• Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G, Karageorgopoulos DE. Comparison of antibiotics with placebo for the treatment of acute sinusitis: a meta-analysis of randomized controlled trials. Lancet Infect Dis 2008;8:543-52.
• Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006;6:438-446.